Author Affiliation: Department of Medicine, University of California, San Francisco.
Bleeding is the most feared complication of anticoagulant therapy and, unfortunately, it is not uncommon. The 2011-2012 National Patient Safety Goals mandate efforts to “reduce the likelihood of patient harm associated with the use of anticoagulant therapy.”1 This is a call for coordinated efforts to decrease adverse events related to anticoagulant therapy, with recommendations for improved oversight and evidence-based management of these agents in the inpatient and outpatient settings.
Minichiello T. Moderate Renal Impairment and Risk of Bleeding With AnticoagulationComment on “Enoxaparin Outcomes in Patients With Moderate Renal Impairment”. Arch Intern Med. 2012;172(22):1718-1720. doi:10.1001/2013.jamainternmed.456